NCT02728934 Comparative and Pragmatic Study of Golimumab Intravenous (IV) (Simponi Aria) Versus Infliximab (Remicade) in Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT02638701 Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms Status RECRUITING Phase PHASE1/PHASE2
NCT02566889 An Efficacy and Safety Study of Infliximab Dose Escalation in Pediatric Participants With Inflammatory Bowel Disease Status TERMINATED Phase PHASE4
NCT02522169 TOPIT; Trough Level Optimized Pediatric Inflammatory Bowel Disease Therapy: A Multicenter Study Comparing Effectiveness of Trough Level Optimized Infliximab Maintenance Therapy With Standard Dosing Regimen of Pediatric Patients With Crohn's Disease Status UNKNOWN Phase NA
NCT02505568 A Study to Evaluate Efficacy and Safety of Infliximab in Participant With Moderate-to-Severe Refractory Intestinal Behcet's Disease Status COMPLETED Phase PHASE3
NCT02495077 Effects of Inhibiting Early Inflammation in Kidney Transplant Patients Status COMPLETED Phase PHASE2
NCT02453607 The Impact of 6MP Metabolite Levels on Infliximab Pharmacokinetics and Anti-infliximab Antibodies in Crohn's Disease Status UNKNOWN Phase N/A
NCT02425852 A Randomized, Multicenter Open Label Study Comparing Early Administration of Azathioprine Plus IFX to Steroids Plus Azathioprine for Acute Severe Colitis Status COMPLETED Phase PHASE4
NCT02363738 12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression Status COMPLETED Phase PHASE2
NCT02298062 Infliximab for Kawasaki Disease Patients Resistant to IVIG : a Multicentre, Prospective, Randomised Trial Status COMPLETED Phase PHASE3
NCT02293681 An Observational Study of Infliximab in Participants Suffering From Ankylosing Spondylitis With Hip Involvement Status TERMINATED Phase N/A
NCT02251041 Combined Drug Approach to Prevent Ischemia-reperfusion Injury During Transplantation of Livers (CAPITL) Status COMPLETED Phase PHASE2
NCT02222493 A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02). Status COMPLETED Phase PHASE3
NCT02177071 A proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination Therapy Status COMPLETED Phase PHASE4
NCT02136069 A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors Status COMPLETED Phase PHASE3
NCT02132234 Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Status UNKNOWN Phase PHASE4
NCT02088944 a Single-center Registered Clinical Research of Chinese Patients With Moderate to Severe Crohn's Disease Status UNKNOWN Phase N/A